Clinical Trial Update: Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization [Phase 4]

View source ↗

Summary

Phase 4 trial update on intra-arterial rhTNK-tPA thrombolysis for acute large vessel occlusion after successful mechanical thrombectomy recanalization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• rhTNK-tPA (recombinant human TNK tissue-type plasminogen activator) (recombinant human TNK tissue-type plasminogen activator)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Acute | Phase 4 | Status: UNKNOWN